Asian Spectator


The Times

.

Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout

  • Written by ACN Newswire - Press Releases

Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout

HONG KONG, Mar 4, 2021 - (ACN Newswire) - Tianda Pharmaceuticals Limited ("Tianda Pharmaceuticals", together with its subsidiaries as the "Group", Stock Code: 455.HK) is pleased to announce that its wholly-owned subsidiary, Tianda Pharmaceutical (Zhuhai) Co., Ltd., has entered into a Technology Transfer Contract with Heilongjiang Jiren...

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-libraryagen bolatelegram下载1xbetGanobetzlibrary.jojobetสล็อตสล็อตgrandpashabetstakejojobetTotalSportStreamEasthitbet girişbetasusjojobetjojobetholiganbetvipparkGalabetDizipalStreamEastPadişahbetgrandpashabetjojobetGalabetcasibomgrandpashabet